TobaccoIntelligence - complete coverage of voting

FDA committee rejects two IQOS MRTP claims, approves one

25th January 2018 - News analysis |

Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction